Can we use B-type natriuretic peptides to monitor patients with heart failure?

被引：0
|
作者：
McDonagh, Theresa A. [1 ]
Gardner, Roy S. [2 ]
Chong, Kwok S. [3 ]
Dargie, Henry J. [2 ]
机构：
[1] Royal Brompton Hosp, London SW3 6LY, England
[2] Glasgow Royal Infirm, Scottish Natl Adv Heart Failure Serv, Glasgow G4 0SF, Lanark, Scotland
[3] So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland
来源：
BIOMARKERS IN MEDICINE | 2007年 / 1卷 / 03期
关键词：
heart failure; monitoring; natriuretic peptides; treatment titration;
D O I：
10.2217/17520363.1.3.349
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The B-type natriuretic peptides (BNPs) now have a well-established role in the diagnosis of heart failure. There is also a wealth of evidence on their ability as prognostic markers in patients with heart failure. The other potential role of BNPs is in the arena of therapy monitoring, although much less is known regarding this putative application. This review summarizes what evidence there is both for and against using BNPs to monitor heart failure patients.
引用
收藏
页码：349 / 353
页数：5
相关论文
共 50 条
  • [1] B-type natriuretic peptides in heart failure
    Gardner, Roy S.
    Chong, Kwok S.
    Mcdonagh, Theresa A.
    BIOMARKERS IN MEDICINE, 2007, 1 (02) : 243 - 250
  • [2] Natriuretic Peptides in Heart Failure Atrial and B-type Natriuretic Peptides
    Maisel, Alan S.
    Duran, Jason M.
    Wettersten, Nicholas
    HEART FAILURE CLINICS, 2018, 14 (01) : 13 - +
  • [3] Can B-type natriuretic peptides replace heart failure risk models?
    Levy, Wayne C.
    EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (03) : 224 - 225
  • [4] Prognostic utility of B-type natriuretic peptides in patients with heart failure and renal dysfunction
    Waldum, Bard
    Stubnova, Viera
    Westheim, Arne S.
    Omland, Torbjorn
    Grundtvig, Morten
    Os, Ingrid
    CLINICAL KIDNEY JOURNAL, 2013, 6 (01): : 55 - 62
  • [5] B-type natriuretic peptides: applications for heart failure management in 2005
    Troughton, RW
    Richards, M
    INTERNAL MEDICINE JOURNAL, 2005, 35 (07) : 377 - 379
  • [6] Advances in The Use of B-type Natriuretic Peptide in Heart Failure
    Yu Yi-Pin
    Tan Duo-Ting
    Yang Liu
    Zhong Li-Qin
    Sheng Dan
    Huang Ru-Jia
    Hu Zhi-Xi
    Liang Hao
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2023, 50 (03) : 486 - 496
  • [7] Interaction on metabolic clearance between A-type and B-type natriuretic peptides in patients with heart failure
    Yoshimura, M
    Mizuno, Y
    Harada, E
    Nakayama, M
    Shimasaki, Y
    Ito, T
    Nakamura, S
    Soejima, H
    Miyamoto, S
    Takazoe, K
    Ogawa, H
    Kugiyama, K
    Saito, Y
    Nakao, K
    Yasue, H
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (09): : 1228 - 1233
  • [8] The therapeutic effect of B-type natriuretic peptides in acute decompensated heart failure
    Caprnda, Martin
    Zulli, Anthony
    Shiwani, Haaris A.
    Kubatka, Peter
    Filipova, Slavomira
    Valentova, Vanda
    Gazdikova, Katarina
    Mozos, Ioana
    Berukstis, Andrius
    Laucevicius, Aleksandras
    Rihacek, Ivan
    Dragasek, Jozef
    Prosecky, Robert
    Egom, Emmanuel E.
    Staffa, Robert
    Kruzliak, Peter
    Krasnik, Vladimir
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2020, 47 (07) : 1120 - 1133
  • [9] B-type natriuretic peptides in heart failure: update on clinical applications and limitations
    Miller, Wayne L.
    Targonski, Paul V.
    Jaffe, Allan S.
    BIOMARKERS IN MEDICINE, 2007, 1 (04) : 503 - 512
  • [10] B-type natriuretic peptide and heart failure: what can we learn from clinical trials?
    Binoun-A-Egom, Christian
    Andreas, Angelo
    Klimas, Jan
    Valentova, Vanda
    Kruzliak, Peter
    Egom, Emmanuel E.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2015, 42 (09) : 881 - 887
12345